Polypragmasia as a risk factor causing complications in viral infection

Abstract

Diverse clinical symptoms combined with limited possibilities of etiotropic therapy, a large number of symptomatic agents became the reasons for polypharmacy in the treatment of coronavirus infection. Unreasonable treatment often slows down the natural healing process. In the majority of patients with caronavirus infection, the disease occurs in a mild or moderate-severe form, approximately 25% develop a severe disease that requires oxygen support [2,3], and 5% have an extremely severe course with complications such as acute respiratory distress syndrome, respiratory failure, septic shock, thromboembolism, sepsis, multiple organ failure, acute kidney and heart damage. Smoking, old age and concomitant diseases, such as heart disease, chronic lung disease, hypertension, diabetes, multiple comorbidities have led to what is currently relevant-polypragmasia. This term refers to the simultaneous unjustified administration of a large number of medicationspolypharmacy